The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.
Risks
and complexities associated with organ transplants necessitate the need for
improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS)
technology is rapidly replacing traditional diagnostic methods, such as
serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing
to the growing demand for high-throughput diagnostic tools with enhanced
accuracy.
Market
growth is expected to be restrained by factors such as reimbursement
controversies and ethical issues in some parts of the world. In addition, the
high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and
NGS devices is challenging the growth of the transplant diagnostics market in
developing countries.
For Full Research Report On Transplant Diagnostics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Further key
findings from the study suggest:
- PCR-based molecular assay
captured the largest share in the overall market in 2016 due to extensive
adoption in HLA typing
- The sequencing-based typing
segment is anticipated to witness significant growth from 2016 to 2024.
High adoption of NGS is a major factor driving segment growth
- In 2016, the reagents and
consumables segment accounted for the largest market share attributed to
repeat purchase
- North America captured the
largest revenue share in 2016 and is expected to maintain its dominance
throughout the forecast period due to well-established research
infrastructure, increasing healthcare expenditure, high adoption of
advanced diagnostic techniques, and growing R&D activities
- Asia Pacific is expected to
witness significant growth during the forecast period owing to expanding
research opportunities, healthcare expenditure, the medical tourism
industry, and awareness regarding organ donation
- Some major players in this
market are Thermo Fisher Scientific, Inc.; Illumina, Inc.; F. Hoffmann
La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant
Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix, Inc.; and
Omixon Ltd.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market/request/rs1
Grand View Research has segmented
the global transplant diagnostics market on the basis of technology, product,
and region:
Transplant
Diagnostics Technology Type Outlook (Revenue, USD Million, 2014 - 2024)
- Molecular Assay
- PCR-based Molecular Assay
- Sequencing-based Molecular
Assay
- Non-molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture
Assay
Transplant
Diagnostics Product Type Outlook (Revenue, USD Million, 2014 - 2024)
- Reagents & Consumables
- Instruments
- Software and Services
Transplant
Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2024)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- Asia Pacific
- Japan
- India
- Latin America
- Mexico
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment